Kenneth B. Kassler-Taub - Feb 28, 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, Regulatory & QA
Signature
/s/ Kenneth B. Kassler-Taub, M.D.
Stock symbol
LXRX
Transactions as of
Feb 28, 2023
Transactions value $
-$41,486
Form type
4
Date filed
3/1/2023, 03:51 PM
Previous filing
Feb 13, 2023
Next filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +18.2K +21.25% 104K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Options Exercise +7.09K +6.81% 111K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Options Exercise +27.6K +24.78% 139K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Tax liability -$41.5K -19.1K -13.78% $2.17 120K Feb 28, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -18.2K -100% 0 Feb 28, 2023 Common Stock 18.2K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -7.09K -50% 7.09K Feb 28, 2023 Common Stock 7.09K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -27.6K -33.33% 55.1K Feb 28, 2023 Common Stock 27.6K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.